全文获取类型
收费全文 | 19014篇 |
免费 | 1026篇 |
国内免费 | 120篇 |
专业分类
耳鼻咽喉 | 132篇 |
儿科学 | 415篇 |
妇产科学 | 485篇 |
基础医学 | 2771篇 |
口腔科学 | 790篇 |
临床医学 | 1792篇 |
内科学 | 3308篇 |
皮肤病学 | 301篇 |
神经病学 | 1541篇 |
特种医学 | 584篇 |
外科学 | 2296篇 |
综合类 | 506篇 |
一般理论 | 41篇 |
预防医学 | 1403篇 |
眼科学 | 1075篇 |
药学 | 1327篇 |
2篇 | |
中国医学 | 61篇 |
肿瘤学 | 1330篇 |
出版年
2024年 | 17篇 |
2023年 | 742篇 |
2022年 | 1059篇 |
2021年 | 1089篇 |
2020年 | 1223篇 |
2019年 | 686篇 |
2018年 | 711篇 |
2017年 | 711篇 |
2016年 | 681篇 |
2015年 | 745篇 |
2014年 | 1379篇 |
2013年 | 1043篇 |
2012年 | 852篇 |
2011年 | 755篇 |
2010年 | 897篇 |
2009年 | 852篇 |
2008年 | 613篇 |
2007年 | 617篇 |
2006年 | 582篇 |
2005年 | 559篇 |
2004年 | 475篇 |
2003年 | 440篇 |
2002年 | 403篇 |
2001年 | 358篇 |
2000年 | 293篇 |
1999年 | 351篇 |
1998年 | 183篇 |
1997年 | 158篇 |
1996年 | 154篇 |
1995年 | 144篇 |
1994年 | 103篇 |
1993年 | 82篇 |
1992年 | 229篇 |
1991年 | 222篇 |
1990年 | 252篇 |
1989年 | 166篇 |
1988年 | 144篇 |
1987年 | 67篇 |
1986年 | 26篇 |
1985年 | 32篇 |
1984年 | 31篇 |
1983年 | 12篇 |
1982年 | 11篇 |
1981年 | 10篇 |
1908年 | 1篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
《Injury》2022,53(2):676-682
Aim3D-printed implants could improve the capture of fracture fragments for improved stability of tibial plateau fracture fixation. The aim of this study was to compare the biomechanical strength of fixation constructs using standard and customised 3D-printed proximal tibial locking plates for fixation of tibial plateau fractures.MethodsThis is a biomechanical study utilising six pairs of cadaveric tibiae. Fractures were created in an identical fashion using an osteotome and mallet, and fixed using either a standard, commercially-available proximal tibia locking plate or a customised 3D-printed plate. Design and production of the customised plates followed a “3D printing at point-of-care” model. Customised stainless steel 316 L plates were produced within a local additive manufacturing laboratory based upon pre-operative CT scans. Determination of implant choice within each cadaver pair was performed via simple randomisation. Following fracture fixation, the tibiae were skeletalised and biomechanically tested using a customised loading jig and a size-matched femoral knee prosthesis. The constructs were loaded cyclically from 100 N to approximately three times the cadaveric body-weight at 5 Hz for 10 000 cycles. Every 1000 cycles, the test was paused and the tibia was physically checked for failure. If failure had not occurred by the end of the testing cycle, the construct was loaded to failure and the load at which the construct failed was noted.ResultsFixation constructs using the 3D-printed plates performed comparably to those using the standard plates. There was no significant difference in the degree of fracture fragment displacement in both constructs. Overall longitudinal construct stiffness and load to failure was higher in the 3D-plates group but this did not reach statistical significance.ConclusionProduction of customised plates for proximal tibia fractures at point-of-care is feasible, however fixation constructs with these plates did not provide any biomechanical advantage over standard plates in terms of axial loading stiffness. 相似文献
22.
23.
A mixed‐method study of effects of a therapeutic play intervention for children on parental anxiety and parents' perceptions of the intervention 下载免费PDF全文
24.
25.
Diabetic macular ischaemia (DMI) is traditionally defined and graded based on the angiographic evidence of an enlarged and irregular foveal avascular zone. However, these anatomical changes are not surrogate markers for visual impairment. We postulate that there are vascular phenotypes of DMI based on the relative perfusion deficits of various retinal capillary plexuses and choriocapillaris. This review highlights several mechanistic pathways, including the role of hypoxia and the complex relation between neurons, glia, and microvasculature. The current animal models are reviewed, with shortcomings noted. Therefore, utilising the advancing technology of optical coherence tomography angiography (OCTA) to identify the reversible DMI phenotypes may be the key to successful therapeutic interventions for DMI. However, there is a need to standardise the nomenclature of OCTA perfusion status. Visual acuity is not an ideal endpoint for DMI clinical trials. New trial endpoints that represent disease progression need to be developed before irreversible vision loss in patients with DMI. Natural history studies are required to determine the course of each vascular and neuronal parameter to define the DMI phenotypes. These DMI phenotypes may also partly explain the development and recurrence of diabetic macular oedema. It is also currently unclear where and how DMI fits into the diabetic retinopathy severity scales, further highlighting the need to better define the progression of diabetic retinopathy and DMI based on both multimodal imaging and visual function. Finally, we discuss a complete set of proposed therapeutic pathways for DMI, including cell-based therapies that may provide restorative potential. 相似文献
26.
27.
28.
29.
《Survey of ophthalmology》2023,68(2):241-256
We quantitatively evaluated the efficacy of antitubercular therapy (ATT) in tubercular uveitis (TBU) patients. Main outcome measures include inflammation recurrence, inflammation reduction, complete resolution of inflammation, improved visual acuity (VA), ability to taper corticosteroids to < 10 mg/day without inflammatory progression, and use of adjunctive immunosuppressants while on ATT. This review is prospectively registered in PROSPERO (CRD42020206845). Forty-nine studies reporting data for 4,017 TBU patients were included. In comparative studies, the odds ratio (OR) of inflammatory recurrence was 0.33 (95%CI:0.19-0.60) for TBU patients treated with ATT±corticosteroid versus no ATT. For TBU patients treated with ATT±corticosteroid, the pooled absolute incidences of inflammatory recurrence, inflammatory reduction, complete resolution of inflammation, and visual acuity improvement were 13% (n=310/2,216; 95%CI:9-18), 81% (n=217/276; 95%CI: 62-95), 83% (n=1,167/1,812; 95%CI: 77-89), and 65% (n=347/542; 95%CI:51-78), respectively. Corticosteroids were tapered to <10 mg/day without inflammatory progression in 91% (n=326/395; 95%CI:78-99) of patients, 9% (n=121/1,376; 95%CI:6-13) of whom were administered concomitant immunosuppressive agents alongside ATT. We conclude that treatment of TBU with ATT±corticosteroid is associated with a high level of control or improvement of inflammation. More prospective studies with detailed reporting of ATT regimens, patient subgroups, and outcomes are required to better evaluate ATT effectiveness. 相似文献
30.